Statistics
Publications
28
Citations
710
H-Index
17
Active since
2012
Donglai Ma is an author at Hebei University of Chinese Medicine specializing in pharmacology, medicine, and molecular pharmacology.
Publications per year
2012–2023
28
28
miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling
Donglai Ma, Xuanchen Tao, Feng Gao et al. · Oncology Letters · 2012 · 80 citations · Full text
Jianguo Li, Lei Yao, Guodong Li et al. · PLoS ONE · 2015 · 47 citations · Full text
Medicine, Cancer Biology, Oncology +17
Yanshuang Liu, Yingran Liang, Bin Zheng et al. · Drug Design Development and Therapy · 2020 · 35 citations · Full text
1–5 of 28